With increasing frequency over the past few years, optometrists across the country have gotten referrals from internists requesting baseline diabetic retinopathy (DR) screenings for patients about to start therapy with one of the glucagon-like peptide-1 (GLP-1)/glucose-dependent insulinotropic polypeptide (GIP) receptor agonists such as semaglutide (Ozempic, Novo Nordisk), tirzepatide (Mounjaro, Eli Lilly) and dulaglutide (Trulicity, Eli Lilly
Stopping medication may increase the likelihood of weight regain if lifestyle habits are not maintained
Previously, people who were taking smaller doses of GLP-1s were either getting them off label from a physician which means they were prescribed, but not based on the protocols approved by the FDA or getting them illegally online and figuring out how to take them on their own
D.KrauseE
economy can all be treated by treating the disease of diseases, Alexander said during Newsweeks event, and so were underestimating the cost of doing nothing, which is not zero. Not covering GLP-1s, is not a neutral financial position, either
However, Hims providers can prescribe semaglutide, which is the same active ingredient found in Ozempic